Regarded as both cytokine and damage-associated molecular pattern, IL-33 is released upon keratinocyte damage in psoriasis then activates inflammatory pathways in an autocrine manner (De la Fuente et al., 2015; Zeng et al., 2021). This evidence concerns the gene IL33 and psoriasis.